Previous 10 | Next 10 |
Rite Aid (NYSE:RAD) is scheduled to announce FQ4 earnings results on Thursday, April 15th, before market open.The consensus EPS Estimate is -$1.02 vs. -$0.37 and the consensus Revenue Estimate is $5.85B (+2.1% Y/Y).Analyst expects comps of (0.2%).Over the last 2 years, RAD has beate...
JPMorgan (NYSE: JPM), Goldman Sachs (NYSE: GS), Delta earnings (NYSE: DAL) along with Coinbase IPO are just some of this week’s main spotlights. Other companies set to report earnings include Bed Bath & Beyond (NASDAQ: BBBY), Wells Fargo & Company (NYSE: WFC), PepsiCo Inc (NA...
Technical analysis provides insights that fundamental observations cannot. We can use that to our advantage in Rite Aid (NYSE: RAD). Using the data offered below we have a real-time example. Review The technical data for RAD below, and the added value of technica...
Deutsche Bank raises price target on RAD to $27. US government increases vaccine reimbursement from $28 to $40 per dose. RAD will benefit from a significantly more dramatic cold/flu season in 2021-2022. For further details see: Rite Aid Remains On Track Despite Projected...
In this episode of MarketFoolery , host Chris Hill and Motley Fool analyst Bill Barker discuss how RH (NYSE: RH) sold a lot of luxury furniture in the fourth quarter, wrapping up a great fiscal year. Also, KB Home (NYSE: KBH) shares fell despite strong first-quarter ...
The next move in a stock's price is often identifiable in advance. This Rite Aid (NYSE: RAD) report attempts to do that, and in the process help investors learn how price acton can be revealing. Trading plans for RAD make these observations actionable, but the data on this p...
Over a year ago, I pointed out the significant, but risky, upside potential of Rite Aid. Shares have soared since then, though the picture for the company fundamentally is still murky. Shares probably offer some upside potential, though the risks associated with the business are s...
Shares of Rite Aid (NYSE: RAD) fell 20% Thursday after the drugstore chain cut its full-year financial outlook. Coronavirus-related social distancing measures have weighed on Rite Aid's revenue and profits. "During the fourth quarter our industry was impacted by a historically s...
Gainers: ProQR Therapeutics (PRQR) +47%.Cellect Biotechnology (APOP) +47%.Houston Wire & Cable (HWCC) +38%.GameStop (GME) +29%.Koss (KOSS) +28%.Cinedigm (CIDM) +28%.F-star Therapeutics (FSTX) +26%.FreightCar America (RAIL) +24%.Polar Power (POLA) +20%.Immutep (IMMP) +20%.Losers:...
Deutsche Bank analyst George Hill writes that although COVID-19 has disrupted the retail pharmacy business, Rite Aid (RAD) is poised as a "positive opportunity" in both the near and long terms.He has initiated a short-term buy rating.Yesterday, Rite Aid shares fell significantly in afte...
News, Short Squeeze, Breakout and More Instantly...
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Compan...
Stein Succeeds Elizabeth “Busy” Burr Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) an...
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment f...